Bovee Courtney E, Pasquale Louis R
a Mass Eye and Ear Infirmary, Department of Ophthalmology , Harvard Medical School , Boston , MA , USA.
b Channing Division of Network Medicine , Brigham and Women's Hospital, Harvard Medical School , Boston , MA , USA.
Semin Ophthalmol. 2017;32(1):91-95. doi: 10.1080/08820538.2016.1228393. Epub 2016 Sep 29.
Interventions in the treatment of mild to moderate glaucoma have evolved to include a group of procedures collectively named "Minimally Invasive Glaucoma Surgery (MIGS)." These procedures are less invasive than traditional filtering surgery and setons and offer the benefit of an improved side-effect profile. A review of current published literature has shown that these procedures offer lower intraocular pressure, decrease reliance on topical medications, have no negative effect on refractive outcomes, and can be safely done following failed tube surgery.
轻度至中度青光眼的治疗干预措施已发展为包括一组统称为“微创青光眼手术(MIGS)”的手术方法。这些手术比传统的滤过性手术和引流管植入术侵入性更小,且具有副作用更少的优点。对当前已发表文献的综述表明,这些手术能降低眼压,减少对局部用药的依赖,对屈光结果无负面影响,并且在引流管手术失败后也能安全进行。